Form 4: Azenta Director Tina Susan Nova Acquires 4,040 Shares of Common Stock
SEC Form 4 Filing
Director Tina Susan Nova acquired 4,040 shares of Azenta, Inc. common stock at a price of $52.32 per share on February 7, 2025.
Summary
- On February 7, 2025, Tina Susan Nova, a director of Azenta, Inc., acquired 4,040 shares of the company's common stock.
- The shares were acquired at a price of $52.32 per share.
- This transaction increased Nova's direct ownership to 10,109 shares.
- The acquisition was a grant of unrestricted shares under the company's 2020 Equity Incentive Plan, with no payment required upon grant.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. A director acquiring shares is generally a good sign, but it's a standard grant under an existing plan.
Positives
- A director's acquisition of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
- The grant of unrestricted shares under the 2020 Equity Incentive Plan suggests a commitment to aligning director interests with shareholder value.
Industry Context
Insider transactions are closely monitored as they can provide insights into a company's prospects. Director-level acquisitions are often viewed positively.
Stakeholder Impact
- Shareholders may view the director's stock acquisition as a positive signal.
- Employees may see the equity incentive plan as a tool for aligning interests and rewarding performance.
Key Dates
| Date | Description |
|---|---|
| 02/07/2025 | Date of transaction: Tina Susan Nova acquired 4,040 shares of Azenta, Inc. common stock. |
| 02/11/2025 | Date of signature for the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.